Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT00068393Phase 2Completed
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
StudychairStart date: 2004-02-24

Research Network

Collaboration Network

15 collaborators·20 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score24%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Renal Cell CarcinomaCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney
Similarity Score15%

howard Safran, MD

Brown University

Related
16 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

Cancer of KidneyProstate Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaProstate Cancer
Similarity Score15%

Chi Fai Ng, MD

Chinese University of Hong Kong

Related
30 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney
Similarity Score15%

Gregory P. Swanson, MD

Deaconess Medical Center, Spokane, Washington

Related
2 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Arif Hussain, MD

University of Maryland Greenebaum Cancer Center

Related
2 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Kenneth J. Pienta, MD, FACP

University of Michigan Rogel Cancer Center

Related
2 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00068393Phase 2StudyChair

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
Completed
NCT00003968Phase 2StudyChair

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer
Completed
NCT00030654Phase 3StudyChair

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Prostate Cancer
Completed

All 3 trials loaded